EANM consensus document on the use of [ 18 F]FDG PET/CT in fever and inflammation of unknown origin.

Soren Hess Edel Noriega-Álvarez Lucia Leccisotti Giorgio Treglia Domenico Albano Anne Roivainen Andor W J M Glaudemans Olivier Gheysens

Published in: European journal of nuclear medicine and molecular imaging (2024)

F]FDG PET/CT has a definite role in the diagnostic pathway with an overall diagnostic yield or helpfulness in 50-60% of patients. A positive scan is often contributory by directly guiding treatment or subsequent diagnostic procedure. However, a negative scan may be equally important by excluding focal disease and predicting a favorable prognosis. Similar results are obtained in specific populations such as ICU-patients, children and HIV-patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
oxidative stress
human immunodeficiency virus
young adults
magnetic resonance imaging
hiv infected
south africa
combination therapy
contrast enhanced
genetic diversity